Pillstats
Rx only · Capsule, Extended Release · Oral

Propafenone Hydrochloride

Propafenone Hydrochloride

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US24 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers8 labelers
Packages44
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 23 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.178$0.356$0.534$0.713Dec 2025Apr 2026Jul 2026
$0.479
Latest avg · Jul 22, 2026
-22%
Since Dec 17, 2025
7
Active US suppliers
41%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2194396588772025 Q12025 Q22025 Q32025 Q42026 Q1
596
Rx · 2026 Q1
52K
Units dispensed
-22%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown9SUPPLYING
Strides Pharma Science Limitedunknown8SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown6SUPPLYING
Zydus Lifesciences Limitedunknown6SUPPLYING
Rising Pharma Holdings, Inc.unknown6SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown3SUPPLYING
NorthStar Rx LLCunknown3SUPPLYING
Upsher-Smith Laboratories, LLCunknown3EXITED 2026

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 13, 2025
    RECALLRecall (Class II): Propafenone Hydrochloride Extended-Release Capsules, USP 325mg,60-count bottles, Rx Only, Mfd for: Northstar Rx LLC, Me…

    CGMP Deviations — Recalling firm: Glenmark Pharmaceuticals Inc., USA — U.S. Nationwide

  • Mar 13, 2025
    RECALLRecall (Class II): Propafenone Hydrochloride Extended-Release Capsules USP, 225mg 60-count bottles, Rx Only, Mfd by: Glenmark Pharmaceutic…

    CGMP Deviations — Recalling firm: Glenmark Pharmaceuticals Inc., USA — U.S. Nationwide

  • Mar 13, 2025
    RECALLRecall (Class II): Propafenone Hydrochloride Extended-Release Capsules 225mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmace…

    CGMP Deviations — Recalling firm: Glenmark Pharmaceuticals Inc., USA — U.S. Nationwide

  • Mar 13, 2025
    RECALLRecall (Class II): Propafenone Hydrochloride Extended-Release Capsules 325mg, 60-count bottle, Rx Only Manufactured by: Glenmark Pharmaceu…

    CGMP Deviations — Recalling firm: Glenmark Pharmaceuticals Inc., USA — U.S. Nationwide